Neogen Chemicals Approves FY26 Audited Results, Recommends Dividend
Neogen Chemicals approved audited FY26 results, reporting a profit after tax of Rs. 46.96 Crore for the year and Rs. 14.66 Crore for the quarter ending March 31, 2026. The board recommended a final dividend of Re. 1 per share. Project costs for Neogen Ionics' Dahej and Pakhajan projects were revised to Rs. 428 Crore and Rs. 1,367 Crore respectively.
The approval of audited financial results and dividend recommendation are material events for shareholders. The revised project costs for the subsidiary are also significant.
The company reported positive financial results and recommended a dividend, indicating good performance and shareholder returns.
Neogen Chemicals Limited announced the outcome of its Board Meeting held on May 16, 2026. The Board approved the Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2026, along with the Audit Reports from M/s. Chandabhoy & Jassoobhoy, Chartered Accountants. The auditors provided an unmodified opinion on the financial results.
The Board also recommended a final dividend of Re. 1 per Equity Share for the Financial Year 2025-26, subject to shareholder approval at the upcoming 37th Annual General Meeting (AGM). The record date for the dividend and the AGM date will be intimated in due course.
Additionally, amendments were approved to the company's "Code for prevention of insider trading in the securities of Neogen Chemicals Limited," with the revised code uploaded to the company's website. Details of Outstanding Qualified Borrowings and Incremental Qualified Borrowings for FY 2025-26 were also provided.
Furthermore, Neogen Ionics Limited (NIL), a wholly-owned subsidiary, provided an update on its Dahej and Pakhajan projects. The revised projected cost for the Dahej project (Phase 1) is Rs. 428 Crore with a timeline of February 2027, and for the Pakhajan project (Phase 2) is Rs. 1,367 Crore with a timeline of March 2027, totaling Rs. 1,795 Crore. These revised timelines and costs are attributed to design optimization and a changeover to Japanese technology, alongside planned equity infusions.
The financial results for the quarter ended March 31, 2026, show a Profit After Tax of Rs. 14.66 Crore, and for the financial year, it is Rs. 46.96 Crore. The company also reported on the insurance claim related to the March 5, 2025, fire incident at its Dahej SEZ Plant, with a balance insurance claim receivable of Rs. 188.96 Crore as of March 31, 2026, which the management considers fully recoverable.
What to do with a filing like this
Neogen Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Neogen Chemicals Limited. Read the original for the full detail.